Your browser doesn't support javascript.
loading
IL-28B is a key regulator of B- and T-cell vaccine responses against influenza.
Egli, Adrian; Santer, Deanna M; O'Shea, Daire; Barakat, Khaled; Syedbasha, Mohammedyaseen; Vollmer, Madeleine; Baluch, Aliyah; Bhat, Rakesh; Groenendyk, Jody; Joyce, Michael A; Lisboa, Luiz F; Thomas, Brad S; Battegay, Manuel; Khanna, Nina; Mueller, Thomas; Tyrrell, D Lorne J; Houghton, Michael; Humar, Atul; Kumar, Deepali.
Afiliação
  • Egli A; Infection Biology, Department of Biomedicine, University of Basel, Basel, Switzerland; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • Santer DM; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • O'Shea D; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada; Division of Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada.
  • Barakat K; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada; Faculty of Pharmacy, University of Alberta, Canada.
  • Syedbasha M; Infection Biology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Vollmer M; Infection Biology, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Baluch A; Division of Infectious Diseases, Moffitt Cancer Center, Tampa, Florida, United States of America.
  • Bhat R; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • Groenendyk J; Department of Biochemistry, School of Translational Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
  • Joyce MA; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • Lisboa LF; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • Thomas BS; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • Battegay M; Infection Biology, Department of Biomedicine, University of Basel, Basel, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Switzerland.
  • Khanna N; Infection Biology, Department of Biomedicine, University of Basel, Basel, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Switzerland.
  • Mueller T; Division of Nephrology, University Hospital of Zurich, Zurich, Switzerland.
  • Tyrrell DL; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • Houghton M; Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada.
  • Humar A; Department of Medicine and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.
  • Kumar D; Department of Medicine and Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada.
PLoS Pathog ; 10(12): e1004556, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25503988
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Linfócitos B / Linfócitos T / Interleucinas / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Imunidade Adaptativa Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS Pathog Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Linfócitos B / Linfócitos T / Interleucinas / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Imunidade Adaptativa Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS Pathog Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Canadá